By InvitationNot Applicable

Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis

United States140 participantsStarted 2025-01-01

Plain-language summary

The goal of this study is to evaluate change in symptoms using semiconductor embedded gloves for hand osteoarthritis.

Age range40 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade \>1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification
✓. Patients age 40-75
✓. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
✓. Patients who are willing and able to sign corresponding research subject consent form.

✕. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
✕. Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months
✕. Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis
✕. Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week
✕. Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome
✕. Patient has a history of peripheral neuropathy
✕. Patient has chronic pain conditions unrelated to hand condition
✕. Patient has auto-immune or auto-inflammatory diseases

Change in pain as measured by the Visual Analog Scale (VAS)

Timeframe: Baseline and weekly for 9 months

NCT IDNCT06744855

SponsorAltoona Center for Clinical Research

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2025-12-31

Who can participate

Age range40 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade \>1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification
✓. Patients age 40-75
✓. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
✓. Patients who are willing and able to sign corresponding research subject consent form.

✕. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
✕. Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months
✕. Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis
✕. Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week
✕. Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome
✕. Patient has a history of peripheral neuropathy
✕. Patient has chronic pain conditions unrelated to hand condition
✕. Patient has auto-immune or auto-inflammatory diseases